Fatty acid-binding protein-3 and renal function decline in patients with chronic coronary syndrome.

"CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest."

"This work was supported by research grants BM10501010039 from Academia Sinica, Taiwan; V112C‐062, V111D63‐002‐MY2‐2, VGHUST112‐G7‐1‐2, V113C‐032, and V113EA‐012 from Taipei Veterans General Hospital, Taipei, Taiwan; and NSTC111‐2314‐B‐A49A‐509‐MY3 from the National Science and Technology Council, Taiwan. The funders played no role in the data collection or preparation of the manuscript."

"The research is based on the “Development of New Biosignatures for Atherosclerosis Cardiovascular Diseases” study, a multicentre cohort registry that prospectively enrolled a series of patients with the chronic coronary syndrome. This study protocol has been published previously. The patients with stable coronary artery disease (CAD) after successful percutaneous coronary intervention (PCI) were included from nine tertiary referral centers in Taiwan from 2012 to 2017."